Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A

por Mills, Reversa R, Pagan, Fernando L
Publicado 2015

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods

por Pahwa, Rajesh, Pagan, Fernando L., Kremens, Daniel E., Saint-Hilaire, Marie
Publicado 2023

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?

por Isaacson, Stuart H., Pagan, Fernando L., Lew, Mark F., Pahwa, Rajesh
Publicado 2022

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease

por Pagan, Fernando L., Wilmarth, Barbara, Torres‐Yaghi, Yasar, Hebron, Michaeline L., Mulki, Sanjana, Ferrante, Dalila, Matar, Sara, Ahn, Jaeil, Moussa, Charbel
Publicado 2020

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies

por Pagan, Fernando L., Torres‐Yaghi, Yasar, Hebron, Michaeline L., Wilmarth, Barbara, Turner, R. Scott, Matar, Sara, Ferrante, Dalila, Ahn, Jaeil, Moussa, Charbel
Publicado 2022

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease

por Fowler, Alan J., Ahn, Jaeil, Hebron, Michaeline, Chiu, Timothy, Ayoub, Reem, Mulki, Sanjana, Ressom, Habtom, Torres-Yaghi, Yasar, Wilmarth, Barbara, Pagan, Fernando L., Moussa, Charbel
Publicado 2021

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy

por Espay, Alberto J., Pagan, Fernando L., Walter, Benjamin L., Morgan, John C., Elmer, Lawrence W., Waters, Cheryl H., Agarwal, Pinky, Dhall, Rohit, Ondo, William G., Klos, Kevin J., Silver, Dee E.
Publicado 2017

Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’...

por Soileau, Michael J., Pagan, Fernando L., Fasano, Alfonso, Rodriguez-Cruz, Ramon, Yan, Connie H., Gupta, Niodita R., Teigland, Christie L., Pulungan, Zulkarnain, Schinkel, Jill K., Kandukuri, Prasanna L., Ladhani, Omar A., Siddiqui, Mustafa S.
Publicado 2023

A Screening Tool to Identify Spasticity in Need of Treatment

por Zorowitz, Richard D., Wein, Theodore H., Dunning, Kari, Deltombe, Thierry, Olver, John H., Davé, Shashank J., Dimyan, Michael A., Kelemen, John, Pagan, Fernando L., Evans, Christopher J., Gillard, Patrick J., Kissela, Brett M.
Publicado 2017

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease

por Pagan, Fernando L., Hebron, Michaeline L., Wilmarth, Barbara, Torres‐Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Arellano, Joy, Howard, Helen H., Peyton, Margo, Matar, Sara, Liu, Xiaoguang, Fowler, Alan J., Schwartz, Sorell L., Ahn, Jaeil, Moussa, Charbel
Publicado 2019

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

por Pagan, Fernando. L., Hebron, Michaeline L., Wilmarth, Barbara, Torres-Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Anjum, Muhammad, Arellano, Joy, Howard, Helen H., Shi, Wangke, Mulki, Sanjana, Kurd-Misto, Tarick, Matar, Sara, Liu, Xiaoguang, Ahn, Jaeil, Moussa, Charbel
Publicado 2020

Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor

por Isaacson, Stuart H., Peckham, Elizabeth, Tse, Winona, Waln, Olga, Way, Christopher, Petrossian, Melita T., Dahodwala, Nabila, Soileau, Michael J., Lew, Mark, Dietiker, Cameron, Luthra, Nijee, Agarwal, Pinky, Dhall, Rohit, Morgan, John, Calakos, Nicole, Zesiewicz, Theresa A., Shamim, Ejaz A., Kumar, Rajeev, LeWitt, Peter, Shill, Holly A., Simmons, Adam, Pagan, Fernando L., Khemani, Pravin, Tate, Jessica, Maddux, Brian, Luo, Lan, Ondo, William, Hallett, Mark, Rajagopal, Apoorva, Chidester, Paula, Rosenbluth, Kathryn H., Delp, Scott L., Pahwa, Rajesh
Publicado 2020